Analyses of Newly Diagnosed HIV Infection in Hong Kong
ConditionHIV -1 Infection
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorChinese University of Hong Kong
About this trial
The goal of the project is to determine the epidemiologic status and changing patterns of HIV infection in Hong Kong. The main question it aims to answer is:
\- what is the molecular pattern and burden of HIV-1 infections over the years
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
adult of age 18 or above, who are
people living with HIV, and
attending the service of an HIV specialist clinic in the public service in Hong Kong
Disqualifiers
travelers or visitors who are temporarily staying in Hong Kong
prisoners
patients with mental illnesses who are unable to make informed decision
patients whose HIV diagnosis was made outside Hong Kong and whose treatment have already started.
Trial population
All adult people living with HIV attending a public clinical service in Hong Kong where HIV diagnosis has recently been made
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
720 Participants
are grouped into 1 trial groupGroup A: people with newly diagnosed HIV infection
Trial outcomes
Primary outcomes
1
main molecular HIV-1 subtype
Proportion of patients infection with HIV-1 subtype B
Time frame
from enrollment to the end of the study at 4 years2
main HIV transmission mode
Proportion of patients who are men who have sex with men
Time frame
from enrollment to end of study at 4 yearsSecondary outcomes
1
changes in HIV molecular pattern
Percentage difference in the proportion of patients with HIV-1 subtype B between the last 2 years versus the first 2 years
Time frame
from enrolment to end of study at 4 years2
Change in transmission mode
Percentage difference in the proportion of patients who are men who have sex with men in the last 2 years versus the first 2 years
Time frame
from enrolment to end of study at 4 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov